Aim: The aim of the present study was to evaluate the analgesic efficacy of Epidural ropivacaine 0.2% in postoperative pain relief. Material & Methods: After obtaining written informed consent, the sample size was calculated using G power software. A routine data based observational study was conducted in the Department of Anaesthesia which involved 200 patients of ASA1 and ASA2 grades, who received Epidural 0.2%Ropivacaine and 200 patients who received Epidural 0.125%bupivacaine postoperatively. All patients were monitored for postoperative pain by the visual analogy scale (VAS), requirement of rescue analgesia, hemodynamic parameters and adverse effects. Results: In the present study, there was 72% male and 28% female in Bupivacaine 0.125% group and 70% male and 30% female in ropivacaine 0.2% group. According to visual analogy score, 2.16 score on day 1 in Bupivacaine 0.125% group and 2.40 in ropivacaine 0.2% group. 48% patients required rescue analgesia in Bupivacaine 0.125% group and 60% in ropivacaine 0.2% group. In the present study, 9% had hypotension adverse effect in Bupivacaine 0.125% group and 2% in ropivacaine 0.2% group. Conclusion: Ropivacaine 0.2% and bupivacaine 0.125% were equally efficacious in terms of VAS pain scores, rescue analgesic requirement, but ropivacaine had a better safety profile in terms of less hypotension and lesser motor block.